Siemens Magnetom

Siemens Magnetom is a line of Magnetic Resonance Imaging (MRI) scanners developed by Siemens Healthineers, a leading Medical Technology company, in collaboration with University of California, Los Angeles (UCLA), Stanford University, and Massachusetts General Hospital. The Siemens Magnetom series is designed to provide high-quality images of the body's internal structures, aiding Radiologists and Clinicians in diagnosing and treating various medical conditions, such as Cancer, Neurological Disorders, and Cardiovascular Disease, at institutions like Johns Hopkins University, University of Oxford, and Harvard Medical School. The development of Magnetom scanners has involved partnerships with Philips Healthcare, General Electric Healthcare, and Toshiba Medical Systems, as well as research collaborations with National Institutes of Health (NIH), European Organization for Nuclear Research (CERN), and German Cancer Research Center (DKFZ).

Introduction

The Siemens Magnetom series has revolutionized the field of Medical Imaging, enabling Healthcare Professionals to non-invasively visualize the body's internal structures, including Brain, Heart, and Liver, at hospitals like Mayo Clinic, Cleveland Clinic, and University of California, San Francisco (UCSF). This technology has been instrumental in improving patient outcomes, particularly in the diagnosis and treatment of Stroke, Tumor, and Multiple Sclerosis, with the help of American Heart Association (AHA), American Cancer Society (ACS), and National Multiple Sclerosis Society (NMSS). The Magnetom series has also facilitated research in Neuroscience, Oncology, and Cardiology at institutions like University of Cambridge, University of Toronto, and University of Melbourne. Furthermore, the Magnetom series has been used in conjunction with other Medical Imaging Modalities, such as Computed Tomography (CT), Positron Emission Tomography (PET), and Ultrasound, at facilities like Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and MD Anderson Cancer Center.

History

The development of the Siemens Magnetom series began in the 1980s, with the introduction of the first Magnetom scanner, which was designed in collaboration with University of California, Berkeley, Massachusetts Institute of Technology (MIT), and University of Edinburgh. Since then, the series has undergone significant advancements, with the introduction of new technologies, such as Magnetic Resonance Angiography (MRA), Magnetic Resonance Spectroscopy (MRS), and Diffusion-Weighted Imaging (DWI), developed in partnership with IBM, Google, and Microsoft. The Magnetom series has been used in various Clinical Trials, including those conducted by National Cancer Institute (NCI), American Heart Association (AHA), and European Medicines Agency (EMA), and has been recognized with awards from RSNA, ISMRM, and IEEE. The series has also been used in research collaborations with University of Chicago, University of Pennsylvania, and University of California, Los Angeles (UCLA), and has been featured in publications like The Lancet, New England Journal of Medicine (NEJM), and Journal of the American Medical Association (JAMA).

Technology

The Siemens Magnetom series utilizes advanced Magnetic Resonance Imaging (MRI) technology, including Superconducting Magnets, Gradient Coils, and Radiofrequency Coils, developed in collaboration with General Electric (GE), Philips, and Toshiba. The series also features advanced Image Reconstruction Algorithms, such as Iterative Reconstruction and Deep Learning, developed in partnership with NVIDIA, Intel, and AMD. The Magnetom series is designed to provide high-quality images with high Spatial Resolution and Temporal Resolution, enabling Radiologists and Clinicians to accurately diagnose and treat various medical conditions, including Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease, at institutions like University of California, San Diego (UCSD), University of Washington, and University of Texas Southwestern Medical Center. The series has also been used in research studies on Neuroplasticity, Synaptic Plasticity, and Neurodegeneration, conducted by National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS), and European Brain Research Institute (EBRI).

Models

The Siemens Magnetom series includes a range of models, each designed to meet specific Clinical and Research needs, including the Magnetom Avanto, Magnetom Skyra, and Magnetom Vida, which have been used at hospitals like University of California, Los Angeles (UCLA), Stanford University, and Massachusetts General Hospital. The series also includes models with advanced features, such as Magnetic Resonance-Guided Focused Ultrasound (MRgFUS), Magnetic Resonance-Guided Radiation Therapy (MRgRT), and Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU), developed in collaboration with Insightec, ViewRay, and SonaCare Medical. The Magnetom series has been used in various Clinical Applications, including Neuroimaging, Cardiovascular Imaging, and Oncology Imaging, at facilities like Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and MD Anderson Cancer Center.

Clinical Applications

The Siemens Magnetom series has a wide range of Clinical Applications, including Neuroimaging, Cardiovascular Imaging, and Oncology Imaging, which have been used to diagnose and treat conditions like Stroke, Tumor, and Multiple Sclerosis, at hospitals like Mayo Clinic, Cleveland Clinic, and University of California, San Francisco (UCSF). The series is also used in Pediatric Imaging, Musculoskeletal Imaging, and Abdominal Imaging, at facilities like Children's Hospital of Philadelphia (CHOP), Hospital for Special Surgery (HSS), and University of California, Los Angeles (UCLA). The Magnetom series has been used in conjunction with other Medical Imaging Modalities, such as Computed Tomography (CT), Positron Emission Tomography (PET), and Ultrasound, at institutions like University of Cambridge, University of Toronto, and University of Melbourne. Furthermore, the Magnetom series has been used in research studies on Neuroplasticity, Synaptic Plasticity, and Neurodegeneration, conducted by National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS), and European Brain Research Institute (EBRI).

Safety and Precautions

The Siemens Magnetom series is designed with safety features to minimize risks to patients and Healthcare Professionals, including Magnetic Field Safety, Radiofrequency Safety, and Cryogen Safety, developed in collaboration with Food and Drug Administration (FDA), European Medicines Agency (EMA), and International Electrotechnical Commission (IEC). The series also includes features to reduce Magnetic Resonance Imaging (MRI)-related Artifacts and Noise, developed in partnership with IBM, Google, and Microsoft. Patients with certain Medical Implants, such as Pacemakers and Implantable Cardioverter-Defibrillators (ICDs), may not be eligible for Magnetom scans, and should consult with their Physician or Radiologist before undergoing a scan, at institutions like University of California, Los Angeles (UCLA), Stanford University, and Massachusetts General Hospital. Additionally, the Magnetom series has been used in research studies on Magnetic Resonance Imaging (MRI)-related safety and precautions, conducted by National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute of Environmental Health Sciences (NIEHS), and World Health Organization (WHO). Category:Medical Imaging